Atypical hyperplasia

Atypical Hyperplasia is a medical condition characterized by abnormal growth of cells in the breast or endometrium. It is considered a precancerous condition and is associated with an increased risk of developing breast cancer or endometrial cancer.

Definition

Atypical Hyperplasia refers to the presence of abnormal cells in the breast or endometrium. The term 'atypical' denotes that these cells differ from normal cells in their size, shape, or organization, while 'hyperplasia' indicates an increase in the number of cells. This condition is not cancer, but it can be a forerunner to the onset of breast cancer or endometrial cancer.

Types

There are two types of Atypical Hyperplasia: Atypical Ductal Hyperplasia (ADH) and Atypical Lobular Hyperplasia (ALH). Both types occur in the breast tissue, but they are distinguished by the location of the abnormal cells. In ADH, the abnormal cells are in the lining of a duct, while in ALH, they are in the lobules.

Risk Factors

Several risk factors are associated with Atypical Hyperplasia. These include age, family history of breast or endometrial cancer, never having been pregnant, late menopause, and hormone therapy, particularly when estrogen is given without progesterone.

Diagnosis

Atypical Hyperplasia is usually diagnosed through a biopsy, which involves removing a small sample of tissue for examination under a microscope. The biopsy can be performed using a fine needle, a core needle, or through a surgical procedure.

Treatment

The treatment for Atypical Hyperplasia depends on the individual patient's risk factors and the extent of the condition. Options may include careful monitoring, medication, or surgery.

Prognosis

While Atypical Hyperplasia increases the risk of developing breast or endometrial cancer, it does not guarantee that cancer will develop. Regular check-ups and preventive measures can help manage the risk.

See Also

• Breast Cancer
• Endometrial Cancer
• Biopsy
• Hormone Therapy